How much does the treatment of each major disease cost? A decomposition of Swiss National Health Accounts

The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
Simon WieserMatthias Schwenkglenks

Abstract

In most countries, surprisingly little is known on how national healthcare spending is distributed across diseases. Single-disease cost-of-illness studies cover only a few of the diseases affecting a population and in some cases lead to untenably large estimates. The objective of this study was to decompose healthcare spending in 2011, according to Swiss National Health Accounts, into 21 collectively exhaustive and mutually exclusive major disease categories. Diseases were classified following the Global Burden of Disease Study. We first assigned the expenditures directly mapping from National Health Accounts to the 21 diseases. The remaining expenditures were assigned based on diagnostic codes and clues contained in a variety of microdata sources. Expenditures were dominated by non-communicable diseases with a share of 79.4%. Cardiovascular diseases stood out with 15.6% of total spending, followed by musculoskeletal disorders (13.4%), and mental and substance use disorders (10.6%). Neoplasms (6.0% of the total) ranked only sixth, although they are the leading cause of premature death in Switzerland. These results may be useful for the design of health policies, as they illustrate how healthcare spending is influenced by the ep...Continue Reading

References

Apr 4, 2001·PharmacoEconomics·B S BloomR Jayadevappa
Aug 25, 2004·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Sheryl Burt Ruzek
Sep 29, 2004·Health Affairs·Kenneth E ThorpePeter Joski
Apr 17, 2008·The Journal of Nervous and Mental Disease·Lindsay M Weiss, Nancy M Petry
Feb 26, 2009·Health Affairs·Charles RoehrigJenny Bryant
Jun 19, 2009·Medical Care·Allison B Rosen, David M Cutler
May 25, 2011·PharmacoEconomics·Allison Larg, John R Moss
Sep 20, 2015·PharmacoEconomics·Eberechukwu OnukwughaC Daniel Mullins
Oct 20, 2015·Bulletin of the World Health Organization·Anthony L BuiJoseph L Dieleman
Oct 27, 2015·Annals of Internal Medicine·Amy S KelleyJonathan S Skinner
Dec 28, 2016·JAMA : the Journal of the American Medical Association·Joseph L DielemanChristopher J L Murray
Nov 9, 2017·JAMA : the Journal of the American Medical Association·Joseph L DielemanChristopher J L Murray

❮ Previous
Next ❯

Citations

Nov 10, 2020·Work : a Journal of Prevention, Assessment, and Rehabilitation·Diogo Henrique Constantino Coledam, Yara Machado da Silva
Jan 13, 2021·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Michael Stucki
Jan 14, 2021·São Paulo Medical Journal = Revista Paulista De Medicina·Paula Becker, Denise Razzouk
Mar 4, 2021·São Paulo Medical Journal = Revista Paulista De Medicina·Paula Becker, Denise Razzouk
May 1, 2021·International Journal of Environmental Research and Public Health·Fiorella Pia SalvatoreMariantonietta Fiore

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.